TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory

Filippo Pietrantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.